Global Community

Tripple Gee Posts ₦1.39 Billion Loss in Q1 2025 as Margins Collapse and Costs Surge Tripple Gee & Company Plc ended its financial year on March 31, 2025 , with a devastating turnaround in performance , plunging from a modest profit of ₦7 million in FY 2024 to a loss after tax of ₦1.39 billion. The result reflects a year of margin deterioration, surging finance costs , and intense cost pressures, putting significant strain on the company's profitability and equity position.

If you're looking to participate in the precious metals bull run but have little knowledge of the sector you might want to take a look a royalty companies. They are insulated against inflation and market downturns in other sectors.

STEELCASE FAIR VALUE ANALYSIS Target Price: $15.60 Valuation Methodology Based on sector-relative P/E analysis , Steelcase appears moderately undervalued. Using TTM EPS of $1.04 and applying the furniture industry average P/E multiple of 15x, the intrinsic fair value equals $15.60 per share.

Red Star Express Plc projects a net cash inflow of ₦145.67 million for the second quarter of 2025 (July–September), signaling strong operational cash generation capacity even amid ongoing capital expenditure and debt servicing. The company expects to end the quarter with ₦726.71 million in cash and cash equivalents , up from ₦581.04 million at the start of the period.

Disclaimer: As a private investor, I share this personal analysis of Titan Cement for educational purposes. This is NOT investment advice This analysis is provided for informational and educational purposes only.

Key Takeaways Coca-Cola is the leading global brand, and it has endured numerous market downturns with its tested business model. The firm's stability, which includes over six decades of raising its dividend and a share price that is half as volatile as the average market, appeals to a certain investor population.

Key Takeaways The CRM landscape is shifting to specialized CRMs for different use cases There is room to increase its market share to 20%. Most efficiency gains have been made, and excess capital will return to shareholders Salesforce will leverage its cloud to create an attractive value proposition.

Key Takeaways Well-diversified drug pipeline with 52 drugs in late-stage approval - a good hedge for its patent expirations Kenvue spin off allows JNJ to focus on its more profitable Medical Devices and Pharmaceuticals segments Continued dividend increases and buybacks are affordable and will help capital returns Post Kenvue, I expect JNJ to grow revenues by 7.5% p.a. from its new baseline of $84B, and at higher margins Some risks around litigation, patent expiry and drug success are present Catalysts Robust Drug Pipeline: 52 Drugs Racing To The Finish Line In Late-Stage Approval The key threat to a pharmaceutical stock is the patent expiration of their high value assets. Should a company lack a product pipeline to bolster its future product portfolio, then losing exclusivity to any one drug can be a hit to the business.

Key Takeaways PayPal is the online payments household brand benefiting from the positive trend in the E-commerce industry. Venmo’s sub-brand is a growth driver, which could reach over $2 billion in annual revenue by 2027.